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Abstract 
Constipation affects many people with multiple sclerosis, negatively impacting on their 
quality of life and well-being. The use of abdominal massage has been reported in several 
populations and has been shown to increase the frequency of defaecation without harmful 
side-effects. Our objective was to undertake a pilot study to determine the feasibility and 
practicality of undertaking abdominal massage in people with multiple sclerosis (MS). 
Following ethical approval 30 patients with MS and constipation were recruited into this 
single blind randomised controlled trial. After the completion of the consent form and base-
line outcome measures participants were randomly allocated to a massage group or a control 
group. A physiotherapist visited both groups weekly for four weeks. The massage group 
participants were provided with advice on bowel management and they or their carers were 
taught how to deliver abdominal massage. It was recommended that the massage was 
performed daily during the four week intervention period. The control group received bowel 
management advice only. Outcomes were measured pre (Week 0) and post treatment (Week 
4), and at Week 8 and included; The Constipation Scoring System (primary outcome), the 
Neurogenic Bowel Dysfunction Score and a bowel diary. Both groups demonstrated a 
decrease in CSS score from week 0 to week 4 indicating an improvement in constipation 
symptoms, however the massage group improved significantly more than the control groups 
(mean difference between groups in score change -5.0 (SD 1.5), 95% CI -8.1, -1.8; t=-3.28, 
df=28, p=0.003).   
Questionnaire response rates and compliance with treatment were high.  
Data analysis results suggested a potential positive effect of the intervention on the symptoms 
of constipation and support the feasibility of a substantive trial of abdominal massage for the 
alleviation of the symptoms of constipation in people with MS.  
 
Introduction 
Bowel dysfunction occurs in 45% to 69% of people with MS (Norvedt et al. 2007). However, 
despite the high prevalence, a Cochrane Review on the ‘Management of faecal incontinence 
and constipation in adults with central neurological diseases’ reported there was remarkably 
little research in this area and concluded that 'no recommendations could be drawn for bowel 
management which must remain empirical' (Coggrave et al. 2006). Constipation is an 
unpleasant and often distressing condition, and within the MS population can affect patients 
at anytime during the disease process (Hinds et al. 1990). Although rarely life threatening, the 
distress associated with constipation can affect the overall well-being of a patient, with 
symptom severity correlating negatively with perceived quality of life (Glia and Lindberg 
1997). It has also been shown that constipation is a source of considerable psychosocial 
disability and can influence patients’ daily lives to such an extent that they can become totally 
preoccupied with the symptoms (Nortvedt et al. 2007; Friedrichsen and Erichsen 2004; 
Wiesel et al. 2000; Hinds and Wald 1989). Such symptoms can range from a headache and 
fatigue to feelings of bloatedness, loss of appetite, nausea, vomiting, overflow incontinence 
and, concomitantly in the MS patient, exacerbated limb spasticity and bladder dysfunction.  
Constipation in people with MS has multiple causes and cannot be linked to a single 
identifiable neurological deficit (Fowler 1997). Three broad types of constipation have been 
identified:-  
Defaecatory disorders - Pelvic floor muscles may be altered leading to pelvic floor 
dyssynergia where the external anal sphincter tightens rather than opens during defaecation, 
which leads to straining and incomplete bowel evacuation (Lembo and Camilleri 2003).  
Transit disorders  - Abnormalities of colonic activity and a slow transit time have been 
shown to cause constipation in those with MS (Chia et al. 1995; Weber et al. 1990; Glick et 
al. 1982). In a study of 6 patients with MS, transit studies revealed 5 had abnormally slow 
transit with delay being primarily in the distal colon (Waldron et al. 1993). Chia et al. (1996) 
have speculated that slow transit might be due to an autonomic nervous system deficit such as 
occurs with a central nervous lesion rostral to the thoracic cord. However, constipation can 
also occur in patients with little general neurological disability due to MS. An alternative 
speculative hypothesis is that slow transit is not due to a specific neurological lesion or 
lesions in the central nervous system, but rather to another mechanism similar to that which 
causes fatigue in the disease, which is not understood (Fowler 1997).  
Other predisposing factors - Constipation may be related to factors such as fibre and fluid 
intake, mobility, general weakness and fatigue. Medications commonly prescribed to patients 
with MS, such as muscle relaxants or anticholinergic drugs, are also known to cause 
constipation (Winge et al. 2003). Finally, psychological factors or behavioural problems may 
also affect toileting. The end result of such influences is a reduced peristalsis which may 
exacerbate a slow bowel transit time, resulting in faecal matter that is harder and dryer than 
normal, causing difficult and often painful defaecation (Winge et al. 2003). 
Abdominal massage for the management of constipation was used as early as 1870, with its 
use reaching a peak in the late 19
th
 and early 20
th
 century, yet by the 1950s the therapies had 
all but disappeared. However, massage has undergone a revival in clinical practice especially 
within the palliative care, oncology and hospice environments (Trevelyan 1996, Cole and 
Stanley 1998). Indeed, the MS Trust and the MS Society both advocate its use for the relief of 
constipation (www.mssociety.org.uk; www.mstrust.org.uk) but there is very little research as 
to its effectiveness. A literature review undertaken in 1999 by Ernst concluded that this 
intervention should be further investigated through more robust trials. Since 1999 several 
studies have been undertaken, however none included participants with MS. Preece (2002) 
reported on a single group study (n=15) within the palliative care setting and concluded that 
11 of the patients reported a decrease in the distressing effect of constipation. Jeon and Jung 
(2005) undertook randomised control trial with 31 patients who had had a CVA comparing a 
group which had abdominal massage (n=16) to a group who did not, and reported a 
significant improvement in frequency of defaecation in the massage group compared to the 
control group. The most recent study, (Lamas et al. 2009) recruited a sample of 60 people 
with constipation which were randomised to two groups; an intervention group which 
received the massage and a control group. These authors concluded that the abdominal 
massage decreased the severity of constipation and increased bowel movements but did not 
lead to decrease in laxative intake. The present paper describes a pilot study on the efficacy of 
abdominal massage for the relief of constipation in people with MS.    
 
Methods 
Ethical approval for the study was obtained from the Office for Research Ethics Committees, 
Northern Ireland (ORECNI: 08/NIRO2/80: 25th September 2008). 
Participants and recruitment (See Figure 1) 
Following consultation with a statistician it was recommended that we recruit 30 participants in 
order to adequately test out the trial procedures and provide a robust estimate of the intervention 
effect size to inform sample size calculations for a definitive randomised controlled trial. 
Participants were recruited over a 6 month period. Participants self-referred in response to 
adverts placed in the Northern Ireland MS Magazine and web-site, and through the PI visiting 
various MS Groups and day centres to discuss the proposed study.  
The project was explained fully to all participants, and an information sheet was provided. The 
initial screening of individuals included a medical history and a pre-trial questionnaire which 
recorded participant's age, time since diagnosis, disease course and Expanded Disability Status 
Scale (EDSS). Included were individuals who were over 18 years of age, had a confirmed 
diagnosis of MS, fulfilled the Rome II criteria for constipation and were able to understand and 
agree to the study protocol. Excluded were those with a medical history of Crohn's disease, 
diverticular disease, colon cancer, rectal bleeding or recent change in bowel function.  
Group allocation 
Written informed consent was obtained from each participant and following completion of 
baseline outcome measures participants were randomly allocated by the physiotherapist using a 
web-based system, (http://www.sealedenvelop.com), to Group 1 (massage group) or Group 2 
(control group). The individual was informed by telephone and a appointment made for the first 
physiotherapist visit.  
 
Intervention  
The intervention period was 4 weeks, with participants in both groups receiving weekly visits 
from the physiotherapist, thus controlling for the potential effects of contact with a clinician. 
During these visits discussions on the patient’s bowel patterns and symptoms were initiated by 
the physiotherapist and advice was given as necessary regarding good defaecation posture, 
adequate fluid intake, and the importance of diet and exercise. 
In addition, Group 1 participants were instructed, at the first and subsequent visits if 
necessary, how to carry out abdominal massage by the physiotherapist. The participant was 
positioned supine with head and shoulders supported and initially the abdomen was assessed 
for flatus, pain and faecal matter in the gut. The massage began with a gentle relaxing stroke 
up the abdominal wall. Four basic strokes were then provided - stroking, effleurage, kneading 
and vibration (see Figure 2). During the visits the patient and carer were instructed in the 
technique and were given the opportunity to practice and ask questions. A teaching DVD 
which demonstrated the techniques was also provided. 
The abdominal, massage protocol lasted approximately 15 minutes and it was advised that it 
should be carried out daily by the participant or their carer. 
 
Outcome Measurement 
Outcome data were gathered at baseline (Week 0), at the end of the intervention phase (Week 
4) and 4 weeks later (Week 8). The questionnaires were administered to participants via 
telephone by an outcome assessor blinded to group allocation. Participants were also asked to 
complete a daily bowel diary during the 7 days prior to baseline, during the 4 weeks of 
intervention, and for 7 days prior to the completion of the week 8 questionnaire.  
 
Primary Outcome Measure   
Constipation Scoring System (CSS: Agachan et al. 1996) 
This is an 8 item questionnaire with items on frequency of bowel movement, difficulty with 
evacuation, feeling of incomplete evacuation, pain, length of time for evacuation, assistance 
with evacuation (e.g. laxatives), number of failed attempts and the duration of problems with 
constipation. The maximum score is 30, with a higher score indicating increased severity. 
 
Secondary Outcome Measures 
Neurogenic Bowel Dysfunction Score (NBDS: Krogh et al. 2005) 
This is a 10 item questionnaire covering frequency of bowel movements (0-6 points), 
headache, perspiration or discomfort before or during defaecation (0-2 points), medication (0-
4 points each), time spent defaecating (0-7 points), frequency of digital stimulation or 
evacuation (0-6 points), frequency of faecal incontinence (0-13 points), medication to prevent 
faecal incontinence (0-4 points), flatus incontinence (0-2 points) and perianal skin problems 
(0-3 points). The maximum score in the NBDS is 47, the higher the score the more severe the 
symptoms with a score of 14 or more rated as severe.  
Multiple Sclerosis Impact Scale (MSIS-29: Hobart et al. 2001) 
This scale was designed to measure the physical and psychological impact of MS. It is a 29-
item questionnaire with two subscores measuring Physical (20 items) and Psychological (9 
items) impact, with higher scores indicating greater impact.  
The Qualiveen Questionnaire (Bonniaud et al. 2005) 
This is a 30 item questionnaire assessing bladder related quality of life in neurological 
patients. Four sub-scales respresenting aspects of patients’ lives (bother with limitations, 
frequency of limitations, fears and feelings) are assessed with response options framed as 5 
point scales with 0 indicating no effect and 4 indicating a high adverse effect. Results can be 
presented by sub-scale and total score. . 
Seven Day Bowel Diary 
This diary recorded for each of 7 consecutive days: 
 Number of times the participant defaecated each day 
 How long the person spent trying to defaecate 
 Type of bowel motion (Bristol Stool Chart) 
 Number of episodes of faecal incontinence 
 Feeling of incomplete evacuation 
 Use of laxatives/enemas 
 Change in medication, diet and fluid intake 
 
Analysis 
Data were entered into a study database by a member of the team who was blinded to 
participants’ group allocation. Analysis was undertaken using SPSS Version 17 with group 
allocation concealed using codes to differentiate between the massage and control arms. 
Comparison of the baseline characteristics of the two study groups was undertaken using the 
independent sample t-test or the chi square test. Changes in scores from pre to post 
intervention (from Week 0 to Week 4 and Week 8) were compared between study groups 
using the independent sample t-test. The distribution of study variables was assessed for 
normality to ensure the use of parametric tests was appropriate. A 5% level of significance 




Of the first 41 people who expressed an interest in the study 30 individuals (12 male and 18 
female) fulfilled the inclusion criteria and were recruited and randomised between March and 
October 2009 (Figure 1). The mean age of the group was 55 years (SD 13; median 56; range 
34-83 years) and mobility (EDSS 2.5) varied from walking unaided (10%) to wheelchair 
bound (40%). There were no statistically significant differences demonstrated between the 
groups in any outcome measures at baseline. 
 
Recruitment, retention and compliance 
All participants remained in the study up to the end of the intervention period (Week 4); one 
participant, from the control group, withdrew due to a relapse before the final outcome 
measures were completed at Week 8.  
In terms of compliance with the abdominal massage, all participants in Group 1 received a 
weekly visit during the intervention period and reported undertaking the massage daily. At 
Week 8 it was reported by 60% of participants that they were continuing with the massage.  
 
Primary Outcome Measure 
Constipation Scoring System  
Both groups’ CSS scores decreased from Week 0 to Week 4 (Table 2, Figure 1) indicating an 
improvement in constipation symptoms, however the massage group improved significantly 
more than the control group (mean difference between groups in score change -5.0 (SD 1.5), 
95% CI -8.1, -1.8; t=-3.28, df=28, p=0.003). There was no difference between groups 
however in CSS score improvement between Week 0 and Week 8 (mean difference between 
groups in score change -1.6 (SD1.5), 95% CI -5.6, 0.6; t=-2.64, df =28, p=0.112).  
 
Secondary Outcome Measures  
Neurogenic Bowel Dysfunction Score  
The NBD score decreased (improved) in the massage group but increased (worsened) in the 
control group (Table 3, Figure 2), the difference between groups being statistically significant 
from Week 0 to Week 8 (mean difference between groups in score change -7.35 (SD 2.4), 
95% CI -12.45, -2.25; t=-2.95, df=27, p=0.006), but not for Week 0 to Week 4 (mean 
difference between groups in score change -4.4 (SD 2.5), 95% CI -9.6, 0.68; t=-1.77, df =28, 
p=0.086). 
 
Bowel Diary  
The frequency of defaecation increased (improved) in both groups but the participants in the 
massage group improved more than the control group (Table 4, Figure 3), the difference 
between groups being statistically significant for the change from Week 0 to Week 4 (mean 
difference between groups in score change -2.2 (SD.58), 95% CI -0.98,-0.97; t = 3.7, df=27, 
p=0.001). 
 
There was no significant change in the use of laxatives or stool consistency in either group, 




There was no significant difference between groups in the Total Qualiveen scores at any time 
point (mean difference between groups in score change (Week 0 to Week 4) -.11 (SD .16), 
95% CI -.45, .23; t=-.673, df=27, p=.506: (Week 0 to Week 8) .29 (SD .25), CI -.23, .81; 
t=1.169; df=25, p=.253). According to Bonniaud et al. (2007) the minimal important 
difference in score to interpret the magnitude of treatment effect is 0.5 in any of the four 
domains. There was an average change of 0.68 from baseline to Week 4 in the massage group 
in the ‘bother’ domain, and similarly an average change of 0.63 from baseline to Week 8 in 
this domain in the Control Group.  
 
Discussion 
This is the first study which has exclusively involved patients with multiple sclerosis 
undertaking a programme involving abdominal massage for the relief of constipation. From 
the findings it would appear that using abdominal massage improves the frequency of 
defaecation. Furthermore, retention in the massage group was 100% and there were no 
adverse incidents reports indicating that it is a feasible intervention for people with MS to 
undertake and that it is amenable to being evaluated within a randomised controlled trial 
design.  
The causes of constipation are multi-factorial and abdominal massage should be used as part 
of an integrated bowel management programme. Both groups received the same advice on 
good defaecation posture, fluid intake, diet and exercise and an improvement in the 
Constipation Scoring System was evident in all participants. However, those that received the 
abdominal massage improved significantly more than those that received the advice only on 
the Constipation Scoring System (p=0.003 95% CI -8.1, -1.8; t=-3.28, df=28) and in the 
frequency of defaecation (p=0.001, 95% CI -0.98,-0.97; t = 3.7, df=27). Anecdotally 
participants also found the abdominal relaxing and it was interesting that the majority of 
participants were keen to undertake the massage themselves as it provided a means of self-
help and empowerment. 
 
There is debate as to the mechanisms of action of abdominal massage on the bowel, with 
several possible explanations. It is thought that rectal loading may be encouraged by 
increasing intra-abdominal pressure, and in some neurological cases it may elicit rectal waves 
which stimulate the somato-autononic reflex and bowel sensation (Liu et al. 2005). The 
mechanical and reflex effect on the gut encourages peristalsis enhancing the mass movement 
of the gut so increasing the strength of the contraction and propulsive force. The function of 
the gastrointestinal tract is also influenced by activity in the parasympathetic division of the 
autonomic nervous system. By sensory stimulation of the parasympathetic division there is 
increased mobility of the muscles of the gut, an increase in the digestive secretions and 
relaxation of the sphincters in the gastrointestinal canal (Allan 2005; Purves et al. 2007). In 
one study of preterm neonates massage influenced weight gain (Diego et al. 2007) by 
increasing vagal activity and gastric motility. 
The findings of the current study support work in other patient populations. The most recent 
of these by Lamas et al. (2009) was a two group randomised study of 60 self-referred 
patients, who fulfilled the Rome 11 criteria for constipation; the massage group (n=30) 
received 8 weeks of abdominal massage administered by a clinician, and the control group 
(n=30) received no additional intervention or contact time. Results demonstrated an increase 
in frequency of defaecation in the massage group, but no change in laxative use. In 2005, a 
two group RCT comparing abdominal massage (n=16) to no massage (n=15) in patients who 
had had a cerebro-vascular accident reported significant advantage for the treatment group in 
terms of increased frequency of defaecation and reduced severity of constipation (Jeon and 
Jung 2005). Preece (2002) reported some relief of symptoms in the palliative care setting. 
Patients were taught the technique at the day-care centre and used it at home. However, the 
study sample size (n=15) was small and there was no control group. Anecdotal evidence and 
expert opinion also suggests abdominal massage to be an effective treatment option for the 
management of constipation, with the added advantage that it is perceived by patients to be 
relaxing and provides relief from ‘trapped wind’ (Longworth 1982, Ferrell-Torry & Glick 
1993, Fraser & Ross-Kerr 1993, Stevenson 1994). Yet rigorous evidence of the effectiveness 
and cost-effectiveness of abdominal massage for the management of constipation is still 
lacking, despite The Royal College of Physicians suggesting some years ago that randomised 
controlled trials were needed to address this evidence gap (Potter et al. 2002). The results of 
the current study add to the available evidence and, following the MRC guidance on 
developing and evaluating complex interventions (MRC 2000), equip us with the information 
needed to undertake a multi-centre RCT adequately powered to detect differences across a 
range of outcomes which are important to patients with MS. 
It was interesting that many of the participants found the Bowel Diary a useful tool both for 
monitoring frequency of defaecation and as an aid to remember to take their laxative 
medication. Some also said it was useful as the Bristol Stool Chart gave them the language to 
use when discussing their constipation with clinicians. Most participants also found the DVD 
demonstrating the massage was very useful, although one participant with partial sight had 
difficulty seeing it.  
All Outcome Measures, except for the Bowel Diary, were completed by telephone 
administration. This was felt an appropriate method for this particular group of patients 
because of the potential problems with eye-sight and although it could be time consuming for 
the RA it facilitated 100% completion.  
There are several limitations to this study. Results should be interpreted with caution due to 
the small sample size which reflects the feasibility nature of the study. Patients self-referred 
to the study and were therefore potentially more motivated than the general MS population, 
and due to the nature of the intervention it was not possible to blind the patient or clinician. 
Abdominal massage also requires a period of time to influence constipation. In the present 
study the duration of the massage (4 weeks) was quite short compared to other studies, for 
example Lamas et al (2009) only found significant differences at week 8, and it may be the 
effect would have continued to increase if the duration of intervention had been longer. 
Furthermore, some participants felt that in applying the massage technique themselves they 
were unable to exert the same pressure achieved by the physiotherapist and also could be 
quite fatiguing. This could reduce the potential effect of the intervention (Lamas et al 2009). 
Although the results of this trial cannot definitively recommend the use of abdominal 
massage it would appear that with adequate training provided to the clinician, patient or carer 
it is has potential in a programme of treatment to help alleviate constipation in people with 
MS  
Conclusion 
This paper describes a feasibility study of the effectiveness of abdominal massage in 
relieving constipation in people with MS. Questionnaire response rates and compliance with 
treatment were high and data analysis results indicated a potential positive effect of the 
intervention on the symptoms of constipation. Further research is now warranted in the form 
of a multi-centre randomised controlled clinical trial with an adequately powered sample size.














Control Group  
Advice only (n=15)  
 
Not meeting inclusion criteria 
(n=5) 
 Refused to participate (n=6) 
4 weeks intervention 
Massage group 
Abdominal massage and 
advice (n=15)  
Week 4 assessment 
(n=15) 
Week 4 assessment (n=15) 
Week 8 assessment (n=14) 
MS Relapses (n=1)  
Week 8 assessment (n=15) 
Figure 2 Massage Technique 
Stroking commenced from the small of the back and followed the dermatome of the vagus 
nerve, over the iliac crests, and down both sides of the pelvis towards the groin. This was 
repeated several times.  
Effleurage strokes followed the direction of the ascending colon across the transverse colon 
and down the descending colon. This was repeated several times with increased pressure to 
stimulate the austral and segmental contractions of the large intestine with the aim of 
propelling the faecal matter along the gut. 
Palmar Kneading is the heart of the massage and tracks down the descending colon, up the 
ascending colon, and down the descending colon once again. Kneading assists in propelling 
the faecal matter along the gut to load the rectum. Finger kneading may be required to break 
up faecal mass. This part of the massage may sometimes be uncomfortable because of the 
deep compression required. 
Effleurage was repeated and continued with a relaxing transverse stroke over the abdomen.  
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Table 2 Change in Constipation Scoring System (CSS) 
 
Change Group n Mean 
difference 
SD Independent 




15 -5.6667 4.5 0.003 Baseline - Week 4 
Gp 2 Control 15 -.6667 3.7  
Baseline – Week 8 Gp 1  
Intervention 
15 -3.6000 4.0 0.112 








Figure 1 Line Graph showing change in CSS 
 































Table 3 Change in Neurogenic Bowel Score (NBS) 
 
Change Group n Mean 
difference 
SD Independent 




15 -4.2667 7.8 0.086 Baseline - Week 4 
Gp 2 Control  15    .2000 5.8  
Baseline – Week 8 Gp 1  
Intervention   
15  -5.0000 6.1 0.006 
 Gp 2 Control  14 2.35711 7.2  
 
Figure 2 Line graph showing change in NBS 
 








































Table 4 Change in Frequency of Defaecation 
 
Change Group n Mean 
difference 
SD Independent 




15 1.7333 .37 .001 Baseline - Week 4 
Gp 2 
Control 
15    -.4286 .44  
 
Figure 3 Frequency of Defaecation 
Group 1 Massage; Group 2 Control  
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